Hydroxychloroquine denied as not medically necessary by Humana?

Humana's specific coverage criteria for hydroxychloroquine are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies Hydroxychloroquine on Medical-Necessity Grounds

Humana's medical-necessity review for hydroxychloroquine examines whether the submitted documentation establishes that the drug is appropriate, necessary, and not merely convenient for the patient's condition. Denials in this category typically occur because the clinical notes were insufficient — missing a confirmed diagnosis, lacking documentation of disease activity or severity, or failing to show that the prescription aligns with evidence-based treatment guidelines. Hydroxychloroquine is used for conditions including lupus and rheumatoid arthritis; Humana's criteria will reference the relevant diagnostic and clinical standards for those conditions.

## Your Right to Appeal

• ACA §2719 / External Review: Independent external review is available after internal exhaustion, generally within approximately four months of the denial notice.
• ERISA §503: Employer-plan members are entitled to a full-and-fair review, including disclosure of the specific criteria applied.
• Expedited review: If the patient's condition is active and urgent (e.g., active lupus flare, joint damage progression), request expedited review.

## What to Gather

1. Diagnosis confirmation — specialist notes (rheumatologist, dermatologist, or other relevant specialist) with a confirmed diagnosis, including the relevant diagnostic criteria met. Ask the specialist to be explicit about the classification criteria used. 2. Disease-activity and severity documentation — recent clinical assessment documenting current disease activity, organ involvement, or functional limitation. Lab findings, examination findings, and validated assessment scores noted in the chart (without relying on specific numeric thresholds here — include what the chart says). 3. Prior treatment history with dates and outcomes — a chronological list of prior medications tried, with start/stop dates and the reason each was discontinued or found insufficient. 4. Prescriber medical-necessity letter — a narrative from the treating physician or specialist explaining the diagnosis, why hydroxychloroquine is medically necessary, and how the patient's case meets the applicable FDA-approved indication. 5. Applicable guideline reference — the prescriber should cite the relevant professional-society guideline (e.g., applicable ACR guideline for the patient's diagnosis) that supports the prescription.

## Criteria-Mapping Approach

Retrieve Humana's published coverage criteria for hydroxychloroquine from your denial letter or Humana's website. Create a two-column table: left column lists each criterion verbatim; right column cites the specific chart entry (date, author, finding) that satisfies it. This structured response removes ambiguity and makes approval straightforward for the reviewer.

## Next Steps

Submit the internal appeal with the full documentation package. If Humana upholds the denial, proceed to external review — independent reviewers regularly reverse medical-necessity denials for hydroxychloroquine when the clinical record is complete and the prescriber's letter directly addresses the criteria.